✦ LIBER ✦

P764 ANALYSIS OF THE EFFECT OF CYCLOPHILIN INHIBITOR ALISPORIVIR ON THE INTERFERON RESPONSE IN HCV-INFECTED CELLS AND PATIENTS

✍ Scribed by Bobardt, M.; Baugh, J.; Gallay, P.; Ma, S.; Kaiser, S.; Hartmann, N.; Letzkus, M.; Staedtler, F.; Riva, A.; Chokshi, S.; Nirmala, N.R.; Johnson, K.J.; Brass, C.A.; Naoumov, N.V.; Li, B.

Book ID: 123492594
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 64 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60925-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, pharmacokinetics, and antiviral

Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy

✍ Eric Lawitz; Eliot Godofsky; Regine Rouzier; Thomas Marbury; Tuan Nguyen; June K 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 620 KB

298 Effects of ribavirin and interferon

298 Effects of ribavirin and interferon alpha combination therapy on T cell-dependent immune responses to HCV proteins in patients chronically infected with HCV

✍ Tony Marion; Inga Warr; Jacquelyn Fleckenstein; Caroline Riely 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Incidence of hepatocellular carcinoma an

Incidence of hepatocellular carcinoma and response to interferon therapy in HCV-infected patients: effect of factors associated with the therapeutic response and incidence of HCC

✍ Hidenori Toyoda; Takashi Kumada 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

The effect of early virological response

The effect of early virological response in health-related quality of life in HCV-infected patients

✍ Lucas C. Quarantini; Ângela Miranda-Scippa; Susana Batista-Neves; Amanda Galvão- 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Twenty‐nine HCV‐infected patients were treated with pegylated interferon alpha. Diagnosis was based on serum HCV RNA‐PCR positive results and liver biopsy. All patients had elevated serum levels of alanine aminotransferase at the time of the study, but liver disease was compensated. Pat

143 EFFICACY AND SAFETY OF INCREASING DO

143 EFFICACY AND SAFETY OF INCREASING DOSES OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A IN TREATMENT NAIVE CHRONIC HCV PATIENTS

✍ R. Flisiak; S.V. Feinman; M. Jablkowski; A. Horban; W. Kryczka; W. Halota; J.E. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

95 EFFICACY AND SAFETY OF THE CYCLOPHILI

95 EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS

✍ D.R. Nelson; R.H. Ghalib; M. Sulkowski; E. Schiff; V. Rustgi; P.J. Pockros; C. W 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB